Canada Pension Plan Investment Board Beam Therapeutics Inc. Transaction History

Canada Pension Plan Investment Board

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$36.73 - $51.6 $77,133 - $108,360	-2,100 Reduced 60.02%	1,399 $54,000
Q3 2022 Nov 14, 2022	SELL	$39.79 - $70.31 $71,622 - $126,558	-1,800 Reduced 33.97%	3,499 $167,000
Q2 2022 Aug 12, 2022	BUY	$29.86 - $62.36 $113,468 - $236,968	3,800 Added 253.5%	5,299 $205,000
Q1 2022 May 13, 2022	BUY	$53.73 - $82.16 $80,541 - $123,157	1,499 New	1,499 $86,000

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.